[
  {
    "ts": "2025-09-26T14:48:49+00:00",
    "headline": "JPMorgan Lifts Gilead Sciences, Inc. (GILD)’s Price Target To $145, Maintains Overweight Rating",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is among the Renaissance Technologies Portfolio: 10 Biggest Stocks. On September 16, JPMorgan analyst Chris Schott lifted the stock’s price target to $145 from $135 while maintaining an Overweight rating for its shares. While the firm left most of its large-cap biopharma estimates unchanged, it adjusted share price targets on a move […]",
    "url": "https://finance.yahoo.com/news/jpmorgan-lifts-gilead-sciences-inc-144849643.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5d78d69b-f563-363a-b657-3eef6cac0234",
      "content": {
        "id": "5d78d69b-f563-363a-b657-3eef6cac0234",
        "contentType": "STORY",
        "title": "JPMorgan Lifts Gilead Sciences, Inc. (GILD)’s Price Target To $145, Maintains Overweight Rating",
        "description": "",
        "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is among the Renaissance Technologies Portfolio: 10 Biggest Stocks. On September 16, JPMorgan analyst Chris Schott lifted the stock’s price target to $145 from $135 while maintaining an Overweight rating for its shares. While the firm left most of its large-cap biopharma estimates unchanged, it adjusted share price targets on a move […]",
        "pubDate": "2025-09-26T14:48:49Z",
        "displayTime": "2025-09-26T14:48:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ad45e965b4e54ca4038c3c524bb47a1a",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "JPMorgan Lifts Gilead Sciences, Inc. (GILD)'s Price Target To $145, Maintains Overweight Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HPirAgICd6zr9mtpz2i_NQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ad45e965b4e54ca4038c3c524bb47a1a.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8hgkCTMO5tEy6h7V.Zk8Xw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ad45e965b4e54ca4038c3c524bb47a1a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-lifts-gilead-sciences-inc-144849643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-lifts-gilead-sciences-inc-144849643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]